Cargando…

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics

OBJECTIVE: To examine the differential diagnostic significance of cerebrospinal fluid (CSF) biomarkers reflecting Alzheimer’s disease-related amyloid β (Aβ) production and aggregation, cortical neuronal damage, tau pathology, damage to long myelinated axons and astrocyte activation, which hypothetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeppsson, Anna, Wikkelsö, Carsten, Blennow, Kaj, Zetterberg, Henrik, Constantinescu, Radu, Remes, Anne M, Herukka, Sanna-Kaisa, Rauramaa, Tuomas, Nagga, Katarina, Leinonen, Ville, Tullberg, Mats
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	General Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817981/ https://www.ncbi.nlm.nih.gov/pubmed/31167811 http://dx.doi.org/10.1136/jnnp-2019-320826

Ejemplares similares

Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients
por: Lukkarinen, Heikki, et al.
Publicado: (2022)

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus
por: Weiner, Sophia, et al.
Publicado: (2023)

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease
por: Jeppsson, Anna, et al.
Publicado: (2022)

Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus
por: Grønning, Rebecca, et al.
Publicado: (2023)

Concordance of Alzheimer’s Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus
por: Lukkarinen, Heikki, et al.
Publicado: (2023)

Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2016)

Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2021)

Amyloid precursor like protein 1 in Idiopathic Normal Pressure hydrocephalus; expanding the knowledge of an altered amyloid metabolism
por: Jeppsson, A, et al.
Publicado: (2015)

Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Vanninen, Aleksi, et al.
Publicado: (2023)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
por: Minta, Karolina, et al.
Publicado: (2021)

Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
por: Lukkarinen, Heikki, et al.
Publicado: (2021)

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2023)

Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients
por: Leal, Nuno Santos, et al.
Publicado: (2018)

Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus
por: Tullberg, Mats, et al.
Publicado: (2008)

Upper limb dysfunction and activities in daily living in idiopathic normal pressure hydrocephalus
por: Sirkka, Jani, et al.
Publicado: (2021)

The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus
por: Yang, Yi, et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus
por: Pyykkö, Okko T., et al.
Publicado: (2014)

Prevalence of Schizophrenia in Idiopathic Normal Pressure Hydrocephalus
por: Vanhala, Vasco, et al.
Publicado: (2019)

Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus
por: Andrén, Kerstin, et al.
Publicado: (2021)

Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein following Bout in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2013)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
por: Neselius, Sanna, et al.
Publicado: (2012)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
por: Teunissen, Charlotte E., et al.
Publicado: (2018)

Survival in treated idiopathic normal pressure hydrocephalus
por: Andrén, Kerstin, et al.
Publicado: (2019)

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
por: Wellington, Henrietta, et al.
Publicado: (2018)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
por: Leitão, Maria João, et al.
Publicado: (2015)

Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective—a cost utility analysis
por: Tullberg, Mats, et al.
Publicado: (2017)

Imaging and CSF analyses effectively distinguish CJD from its mimics
por: Rudge, Peter, et al.
Publicado: (2018)

In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome
por: Giannini, Giulia, et al.
Publicado: (2022)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT)-perfusion
por: Ziegelitz, Doerthe, et al.
Publicado: (2015)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case
por: Korhonen, V. E., et al.
Publicado: (2017)

Increased γ-Secretase Activity in Idiopathic Normal Pressure Hydrocephalus Patients with β-Amyloid Pathology
por: Laiterä, Tiina, et al.
Publicado: (2014)

Long-term effects of complications and vascular comorbidity in idiopathic normal pressure hydrocephalus: a quality registry study
por: Andrén, Kerstin, et al.
Publicado: (2017)

Influence of vascular risk factors and vascular disease on long-term outcome in idiopathic Normal Pressure Hydrocephalus; a Quality Registry based study
por: Andrén, Kerstin, et al.
Publicado: (2015)

Repeated lumbar punctures within 3 days may affect CSF biomarker levels
por: Olsson, Martin, et al.
Publicado: (2019)

Physical exercise and goal attainment after shunt surgery in idiopathic normal pressure hydrocephalus: a randomised clinical trial
por: Rydja, Johanna, et al.
Publicado: (2021)

MRI diffusion and perfusion alterations in the mesencephalon and pons as markers of disease and symptom reversibility in idiopathic normal pressure hydrocephalus
por: Agerskov, Simon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrq2katlefii1kr5ok6icor4nf